Skip to main content

Inozyme Pharma, Inc.

INZYDelisted Jul 1, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001693011

Inozyme Pharma, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 3, 2025; 87 institutions reported holding it in 13F filings for Q2 2025, worth $202.3M in total; no superinvestor held it.

13F holders, Q2 2024

Institutional positions in Inozyme Pharma, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
90
+1 vs. Q1 2024
Shares held
53.8M
+3.95M (+7.9%) vs. Q1 2024
Total value
$240.1M
−$142.0M (−37.2%) vs. Q1 2024
New holders
20
38 more added
Sold out
19
20 more reduced

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting INZY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 90 institutions
Q1 2021: 55 institutionsQ2 2021: 50 institutionsQ3 2021: 52 institutionsQ4 2021: 51 institutionsQ1 2022: 50 institutionsQ2 2022: 47 institutionsQ3 2022: 39 institutionsQ4 2022: 37 institutionsQ1 2023: 50 institutionsQ2 2023: 74 institutionsQ3 2023: 77 institutionsQ4 2023: 80 institutionsQ1 2024: 89 institutionsQ2 2024: 90 institutionsQ3 2024: 89 institutionsQ4 2024: 105 institutionsQ1 2025: 97 institutionsQ2 2025: 87 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2024: $240.1M
Q1 2021: $379.4MQ2 2021: $337.1MQ3 2021: $202.7MQ4 2021: $118.2MQ1 2022: $71.2MQ2 2022: $149.4MQ3 2022: $82.7MQ4 2022: $30.4MQ1 2023: $183.4MQ2 2023: $190.3MQ3 2023: $204.6MQ4 2023: $213.3MQ1 2024: $382.0MQ2 2024: $240.1MQ3 2024: $285.5MQ4 2024: $145.1MQ1 2025: $42.5MQ2 2025: $202.3MQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding INZY and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 202587$202.3M
Q1 202597$42.5M
Q4 2024105$145.1M
Q3 202489$285.5M
Q2 202490$240.1M
Q1 202489$382.0M
Q4 202380$213.3M
Q3 202377$204.6M
Q2 202374$190.3M
Q1 202350$183.4M
Q4 202237$30.4M
Q3 202239$82.7M
Q2 202247$149.4M
Q1 202250$71.2M
Q4 202151$118.2M
Q3 202152$202.7M
Q2 202150$337.1M
Q1 202155$379.4M

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding Inozyme Pharma, Inc.; share changes are against Q1 2024.

Institutions holding INZY in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Denali Advisors LLC0$00.00%−22,000−100.0%Sold out
Bridgeway Capital Management, LLC0$00.00%−17,800−100.0%Sold out
Lido Advisors, LLC0$00.00%−17,108−100.0%Sold out
SG Americas Securities, LLC0$00.00%−13,926−100.0%Sold out
Metropolitan Life Insurance Co0$00.00%−2,728−100.0%Sold out
EntryPoint Capital, LLC0$00.00%−1,460−100.0%Sold out
Signaturefd, LLC0$00.00%−113−100.0%Sold out
ICA Group Wealth Management, LLC0$00.00%−85−100.0%Sold out
Nelson, Van Denburg & Campbell Wealth Management Group, LLC0$00.00%−9−100.0%Sold out